U.S. Online Retail and Ecommerce Stock News

Natera and Eledon Pharmaceuticals announced a partnership to use the Prospera test in a global Phase 3 kidney transplant trial. Prospera will serve as the exclusive molecular monitoring assay for longitudinal surveillance in this large-scale study. The trial focuses on a novel immunosuppression therapy for kidney transplant recipients. Natera, traded as NasdaqGS:NTRA, is extending its reach in transplant diagnostics with this new role for Prospera in a pivotal clinical trial. The company’s...

Darden Restaurants (DRI) just wrapped up FY 2026 with fourth quarter revenue of US$3.7 billion and basic EPS of US$3.57, set against trailing twelve month revenue of US$12.8 billion and EPS of US$9.56. Over recent periods, revenue has moved from US$3.2 billion in Q4 FY 2025 to US$3.7 billion in Q4 FY 2026, while quarterly EPS went from US$2.60 to US$3.57, giving investors a clear view of how the top and bottom lines have tracked into the latest release. With a trailing net margin of 8.7%...

ExlService Holdings (NasdaqGS:EXLS) has agreed to acquire iMerit, a provider of AI model training, reinforcement learning tools, and expert talent. The deal is aimed at broadening EXL's enterprise AI services and integrating iMerit's capabilities into its existing data and analytics platforms. This transaction marks a shift in EXL's business mix toward higher value AI technology offerings for large corporate clients. ExlService Holdings enters this deal with iMerit while its share price...

DexCom is rolling out a redesigned Stelo app in July that aims to provide more accessible and actionable glucose insights to users. The company is preparing to launch Stelo in the UK, Australia, New Zealand, and South Korea, marking a push into new international markets. These moves follow recent FDA clearance for over the counter pediatric use of Stelo in the U.S. DexCom, trading on NasdaqGS:DXCM, is making these product and geographic moves as its stock trades around $70.14. The share...

NetApp launched StorageGRID 12.1, a new release designed for AI scale workloads and modern data use cases. The company expanded its global alliance with CGI to offer subscription based, AI ready data infrastructure across hybrid cloud environments. These moves aim to support enterprises operating across globally distributed settings with higher performance and security for AI and data intensive applications. NetApp (NasdaqGS:NTAP) is drawing fresh attention as it pushes deeper into AI...

If you are wondering whether Yum! Brands stock is offering fair value or hiding a margin of safety, the starting point is to line up its recent share performance with what investors are currently paying for it. The stock last closed at US$156.41, with returns of 2.9% over the past week, 2.9% over the past month, 3.9% year to date, 7.4% over 1 year, 19.6% over 3 years and 46.9% over 5 years. This helps frame how the market has been pricing Yum! Brands over different holding periods. Recent...

Earlier in June 2026, CMA CGM S.A. and Capital Clean Energy Carriers Corp. formed a 50/50 joint venture to build, charter, and operate a 20,000 cbm dual-fuel LNG bunkering vessel, ordered from Nantong CIMC Sinopacific Offshore & Engineering for US$82.8 million with delivery targeted for the third quarter of 2028. This move marks Capital Clean Energy Carriers’ entry into the LNG bunkering market, backed by an expected 12-year time charter with a CMA CGM–TotalEnergies venture that could...

If you are wondering whether Tyler Technologies is attractively priced or still has room to fall, the recent share performance gives a clear starting point for assessing value. The stock last closed at US$294.40, with a gain of 5.6% over the past week, but it remains down 2.7% over the past month, 32.5% year to date and 49.3% over the past year. These moves have come alongside ongoing interest in how Tyler Technologies is positioned in the software sector and how investors are reassessing...

Biogen (NasdaqGS:BIIB) is shifting its focus from older multiple sclerosis and Spinraza products to newer drugs in Alzheimer's, Friedreich’s ataxia, ALS, and depression. The company is leaning on recently launched therapies such as Leqembi, Skyclarys, Qalsody, and Zurzuvae to help offset pressure on its legacy franchises. This transition comes as competition from generics and biosimilars weighs on Biogen’s established revenue base. Biogen sits at the center of several high-profile treatment...

Republic Bancorp (RBCA.A) is back on investors’ radar after its latest earnings report showed revenue declining and missing expectations, while net interest income exceeded forecasts. This highlighted a resilient core banking engine despite sector pressures. See our latest analysis for Republic Bancorp. Since the earnings release, Republic Bancorp’s share price has gained momentum, with a 7 day share price return of 5.45% and a 90 day share price return of 29.14%, while the 3 year total...

Sunrun (RUN) has drawn fresh attention after announcing an agreement with Tesla Energy Operations and Renew Home to aggregate more than 16 gigawatts of flexible residential capacity for utilities and hyperscale data centers across the U.S. See our latest analysis for Sunrun. Sunrun’s agreement arrives after a sharp rebound in sentiment, with the stock’s 1 year total shareholder return of 81.56% contrasting with a year to date share price decline of 30.61%. This suggests that momentum has...

In recent days, analyst concerns about slowing North American snacks demand and rising input costs have led to trimmed earnings estimates for PepsiCo ahead of its July 9 second-quarter report. These revisions highlight how pressure on PepsiCo’s core U.S. food segment is increasingly central to how investors assess the balance between its mature domestic business and stronger international operations. We’ll now examine how analyst estimate cuts tied to North American snacks softness may...

Ingevity (NGVT) has drawn fresh attention after recent share price moves, prompting investors to reassess how its current valuation lines up with fundamentals such as segment mix, recent returns and profitability trends. See our latest analysis for Ingevity. The latest move takes Ingevity's share price to $77.12, with a 1-month share price return of 11.88% and a year-to-date share price return of 28.34%. The 1-year total shareholder return of 77.86% contrasts with a 5-year total shareholder...

Strive (ASST) has drawn fresh attention after recent trading left the stock well below its past year level, with both short term moves and longer term declines prompting investors to reassess risk and potential reward. See our latest analysis for Strive. At the latest share price of $11.34, Strive’s 7 day share price return is down 23.64% and the 30 day share price return is down 36.36%, while the 1 year total shareholder return has declined 85.50%. This suggests recent momentum has been...

Electric vehicle headlines are noisy right now, with Rivian warning that companies sticking with fossil fuel priorities may fall behind, while major automakers have written off over $70b in EV projects and US policy shifts have cooled incentives. For investors, that mix of caution and long term ambition can create mispricing, both on the upside and downside. This article looks at three stocks from an EV focused screener that are directly exposed to these news catalysts, each with potential...

Tariffs on digital services are back in the headlines, and this time the threat is a 100% levy on countries that tax large U.S. platforms like Meta, Alphabet, and Amazon. That kind of policy shock can quickly change how investors think about global exposure, profit margins, and where risk is really coming from. This article looks at three large U.S. technology stocks from a dedicated screener that are closely linked to the digital tax debate, and explains how this news could work for or...

Worthington Steel (WS) has just reported FY 2026 results, with Q4 revenue of $929.2 million and a basic EPS loss of $0.98. This caps a trailing twelve month period where revenue totaled $3.4 billion and EPS came in at $0.35. Over recent quarters, the company has seen revenue move from $832.9 million and EPS of $1.13 in FY 2025 Q4 to a range between $769.8 million and $929.2 million, with EPS spanning from $0.21 to a loss of $0.98 in FY 2026. This sets a mixed backdrop for its latest release...

MarketAxess Holdings (MKTX) has drawn fresh attention after launching TraX Tape, a bond market data solution aimed at simplifying UK and EU transparency reforms while giving clients a single, cleaner view of global trading activity. See our latest analysis for MarketAxess Holdings. Despite the launch of TraX Tape and a recent quarter where MarketAxess Holdings reported year-on-year revenue and net income growth, the stock’s recent momentum has been weak. The share price is down 36.97% year to...

GitLab (GTLB) is in focus after releasing an AI Accountability Report showing many organizations generate AI assisted code faster than they put governance in place, raising questions about safety, reliability, and oversight. See our latest analysis for GitLab. Alongside the AI Accountability Report and a recent leadership change in its legal function, GitLab’s short term momentum has picked up, with a 90 day share price return of 42.85%, even though the year to date share price return is down...

Capstone Energy+ (OTCPK:CGEH) has just wrapped up FY 2026 with fourth quarter revenue of US$23.0 million and basic EPS of US$0.06, alongside trailing twelve month revenue of US$106.0 million and basic EPS of US$0.14 that capture its recent move into profitability. Over the past six reported quarters, revenue has ranged between US$20.1 million and US$28.4 million per quarter, while quarterly EPS has swung from a loss of US$1.79 to a profit of US$0.06. This gives investors a clear view of how...

With BlackRock trading at a last close of US$964.71, many investors are asking a simple question: is the stock pricing in too much optimism, or is the current level still reasonable value for the long term. Over the past week the share price declined 8.1%, adding to a 9.9% fall over the last month and an 11.1% decline year to date, even though the 3 year return sits at 49.5% and the 5 year return at 21.8%. Recent news around BlackRock has focused on its role as a major global asset manager...

Nabors Industries has recently benefited from steady drilling demand and rising rig day rates in the Lower 48, helped by softer crude prices following an interim US–Iran deal and restored oil flows through the Strait of Hormuz. This combination of stable rig activity and improving day-rate economics highlights how Nabors can potentially gain even when headline oil prices soften. Next, we’ll examine how firmer rig demand and higher day rates could influence Nabors Industries’ existing...

Crinetics Pharmaceuticals (CRNX) has attracted fresh attention after recent trading moves, prompting investors to reassess how its clinical-stage pipeline and current share performance might align with individual risk tolerance and time horizon. See our latest analysis for Crinetics Pharmaceuticals. Recent trading has been choppy for Crinetics Pharmaceuticals, with a 1 day share price return of 4.89% and a 90 day share price return of 9%, while the year to date share price return has declined...

Beam Therapeutics announced in June 2026 that the FDA cleared its IND application for BEAM-304, an in vivo base-editing therapy delivered via intravenous lipid nanoparticles to treat phenylketonuria (PKU) by correcting mutations in the PAH gene. A distinctive element of this program is Beam’s platform-style trial design, which aims to test multiple mutation-specific base editors for PKU within a single clinical framework, reflecting the FDA’s emerging guidance to accelerate genome-editing...